title: Integrating novel agents into the curative treatment of head and neck cancer.
authors.forename: Robert
authors.initials: R
authors.lastname: Haddad
authors.forename: Aaron
authors.initials: A
authors.lastname: Allen
authors.forename: Lori
authors.initials: L
authors.lastname: Wirth
authors.forename: Roy
authors.initials: R
authors.lastname: Tishler
authors.forename: Marshall
authors.initials: M
authors.lastname: Posner
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D003131:Combined Modality Therapy; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D006801:Humans
chemical_list: D000970:Antineoplastic Agents; D066246:ErbB Receptors